168 Indeed, liver biopsies confirm that the prevalence of clinically significant fibrosis in MASLD and MASH patients is only 20.27% and 35.14%, respectively, 169 with lower proportions in patients with normal or lean body weight, 170 suggesting that antifibrotic treatment may not be necessary for a larger proportion of patients
Dietary modifications can reduce gastrointestinal symptoms
Someone who cannot control food intake despite genuine effort might need appetite-targeting compounds first
J Endocrinol , 217 (2), 185-196
California is joining several other states in restricting an option they say is no longer affordable as they confront soaring pharmaceutical costs and steep Medicaid cuts under the Trump administration, among other financial pressures
Many lawsuits filed against Novo Nordisk allege that Ozempic users experienced severe and prolonged vomiting, delayed gastric emptying, bowel obstruction, and serious eye conditions such as anterior ischemic optic neuropathy